Tevogen Bio
Warren · Founded 2020
About Tevogen Bio
Tevogen Bio is a clinical-stage biotech company developing curative and preventative treatments to positively impact global public health. Tevogen is developing T cell immunotherapies in virology, oncology, and neurology by utilizing patented precision T cell platform technology. Its current intellectual property portfolio includes several breakthrough cell and gene therapy platforms.
Company Facts
- Founded: 2020
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Total funding: $67.0M
- Funding stage: IPO
- Last round: Post-IPO Debt (Aug 2025)
- Ticker: nasdaq:TVGN
- Website: https://tevogen.com
- Phone: 1 877 838-6436
Industries & Categories
Biotechnology, Health Care, Life Science, Medical, Oncology
Social Profiles
Canonical: https://fsome.com/organization/tevogen-bio-72256 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.